Canadian Cancer Society

Analysis

Canadian Cancer Society is a registered charity in United States, based in Canada. It received its IRS tax-exemption ruling in May 1959, 67 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3).

In the financial year ending January 2024, Canadian Cancer Society reported income of $125.5m and spending of $121.8m, spending 97% of its income. Across the 6 years on record, from January 2019 to January 2024, income fell from $134.1m to $125.5m (-6.4%), an average of -1.3% a year. The sharpest change came in the year to January 2022, when income rose by 16%. Over the whole period it spent 94% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Canadian Cancer Society sits at the 96th percentile: it is larger than about 96% of them. Against every charity in United States with reported income it ranks in the 99th percentile. Charities of a similar size with the same main cause include LMW Healthcare Inc ($125.3m), Concordia Community Support Services ($125.5m) and Foundation Medical Partners Inc ($125.3m).

On its Form 990 for the period ending January 2024, revenue came from contributions and grants 98% of the total. Compensation of current officers, directors and key employees was $1.7m (1.4% of expenses). Other salaries and wages came to $34.4m. It paid $531k in professional fundraising fees. At year end it held assets of $202.4m against liabilities of $76.3m, net assets of $126.1m.